08.03.2025 21:30
Turkey's Minister of Labor and Social Security, Vedat Işıkhan, announced that the medication used in the treatment of Hemophilia A patients has been included in the reimbursement coverage.
Elbette, mevcut HTML yapısını bozmadan metni İngilizce'ye çevirebilirim. İşte çeviri:
```html
The Minister of Labor and Social Security, Vedat Işıkhan, announced that the medication used in the treatment of Hemophilia A patients has been included in the reimbursement scope.
Minister Işıkhan announced a new step regarding the medication used for the treatment of Hemophilia A patients. In a statement made via social media, Işıkhan announced that the medication has been included in the reimbursement scope.
INCLUDED IN THE REIMBURSEMENT SCOPE
Işıkhan stated in his post, "With the Health Implementation Communiqué published in the Official Gazette, we have included the medication that can be easily administered subcutaneously at home for our Hemophilia A patients in the reimbursement scope. This treatment can be applied at home without the need for intravenous access in the hospital, and it provides great convenience, especially for our children with Hemophilia A and their families," he said.
```
Eğer başka bir isteğiniz varsa lütfen belirtin!